Molecular testing provides detailed information that traditional histological techniques might miss. It allows for the identification of specific genetic mutations and biomarkers that can inform targeted therapies. For instance, mutations in the EGFR gene in lung cancer can predict responsiveness to certain tyrosine kinase inhibitors.
